Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2003
11/25/2003US6652862 Biologically active bactericidal/permeability-increasing protein fragments
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/20/2003WO2003095982A1 Wavy interface mixer
11/20/2003WO2003095976A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003WO2003095661A1 Lyophilized preparation for synthesis of cell-free protein
11/20/2003WO2003095644A1 Novel proteins and dnas thereof
11/20/2003WO2003095614A2 Cytokine polypeptides
11/20/2003WO2003095482A2 Novel cyclic peptides and use thereof as anti-microbial agents
11/20/2003WO2003095449A1 Small molecules for inhibition of function and drug delivery to leukocytes
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094844A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003WO2003074546A8 Streptavidin-binding peptide
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003057828A3 Method of producing glycoproteins having reduced complex carbohydrates in mammalian cells
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003045993A3 Protein biopolymer markers predictive of type ii diabetes
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003042363A3 Eit-6, a polypeptide encoded by an estrogen regulated gene
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003040344A3 Transcription factor stress-related polypeptides and methods of use in plants
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003027315A3 Amidases, nucleic acids encoding them and methods for making and using them
11/20/2003WO2003020909A3 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
11/20/2003WO2003020764A3 Modified factor ix
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003009816A3 Facile detection of polycythemia vera
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002103026A3 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002085310A3 Antibiotics aa-896
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002070698A3 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002057794A3 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002014525A3 Expression vector using for animal cell
11/20/2003US20030217385 Comprises insect-toxic peptide/fusion proteins for use in generating disease resistant plants; biological pest control; disease resistant plants
11/20/2003US20030217373 Transgenic animals bearing human Ig-lambda light chain genes
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216549 Comprises modified chemokine for use as antiinflammatory, viricidal or antiallergenic agent
11/20/2003US20030216548 Sp110, a polypeptide component of the nuclear body
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215895 Immunoglobulin for diagnosing and prognosticating human cancer
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215824 Identifying modulators of apoptosis such as XIAP associated factor 1 (XAF-1); for treating and diagnosing cell proliferative disorders; drug screening; antiproliferative agents
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215803 Isolated polynucleotide which hybridizes to given sequence; use in diagnosing cancer and for inhibiting tumor growth
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003CA2487236A1 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003CA2485827A1 Lyophilized preparation for synthesis of cell-free protein
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2484845A1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003CA2483698A1 Cytokine polypeptides
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362120A1 Method for purification of soluble ssao
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362093A1 Rapid production of monoclonal antibodies
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362060A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
11/19/2003EP1362058A2 Comparative ligand mapping from mhc positive cells
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 1125